找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Metronomic Chemotherapy; Pharmacology and Cli Guido Bocci,Giulio Francia Book 2014 The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
查看: 22853|回復(fù): 58
樓主
發(fā)表于 2025-3-21 18:51:42 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Metronomic Chemotherapy
副標題Pharmacology and Cli
編輯Guido Bocci,Giulio Francia
視頻videohttp://file.papertrans.cn/633/632498/632498.mp4
概述Covers all aspects of metronomic chemotherapy.Describes the pharmacological bases of metronomic chemotherapy.Presents and discusses the clinical results of all published studies on metronomic chemothe
圖書封面Titlebook: Metronomic Chemotherapy; Pharmacology and Cli Guido Bocci,Giulio Francia Book 2014 The Editor(s) (if applicable) and The Author(s), under e
描述This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemotherapy in a wide variety of tumors are then addressed in detail, with description of the results of all published studies. The clinical pharmacology of metronomic chemotherapy is also considered in depth, encompassing pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions. The book closes by describing the role of this therapy in the veterinarian clinic.
出版日期Book 2014
關(guān)鍵詞Antiangiogenic drugs; Cancer; Metronomic chemotherapy; Pharmacology
版次1
doihttps://doi.org/10.1007/978-3-662-43604-2
isbn_softcover978-3-662-51319-4
isbn_ebook978-3-662-43604-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag GmbH, DE
The information of publication is updating

書目名稱Metronomic Chemotherapy影響因子(影響力)




書目名稱Metronomic Chemotherapy影響因子(影響力)學(xué)科排名




書目名稱Metronomic Chemotherapy網(wǎng)絡(luò)公開度




書目名稱Metronomic Chemotherapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Metronomic Chemotherapy被引頻次




書目名稱Metronomic Chemotherapy被引頻次學(xué)科排名




書目名稱Metronomic Chemotherapy年度引用




書目名稱Metronomic Chemotherapy年度引用學(xué)科排名




書目名稱Metronomic Chemotherapy讀者反饋




書目名稱Metronomic Chemotherapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:17:04 | 只看該作者
Book 2014preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemot
板凳
發(fā)表于 2025-3-22 04:20:43 | 只看該作者
Development and Evolution of the Concept of Metronomic Chemotherapy: A Personal Perspectiveetronomic chemotherapy concept is summarized along with suggestions for improving its impact as a promising means of achieving better and less toxic cancer control, not only in patients in low and middle income countries, but also patients in highly developed high income countries as well.
地板
發(fā)表于 2025-3-22 06:21:44 | 只看該作者
5#
發(fā)表于 2025-3-22 09:15:00 | 只看該作者
Clinical Activity of Metronomic Chemotherapy in Central Nervous System Cancersma models and numerous clinical applications of metronomic regimens (e.g. etoposide, temozolomide) for adult patients with tumors of CNS have been described. Moreover, metronomic treatment may serve as a useful platform for combination strategies in certain CNS tumors.
6#
發(fā)表于 2025-3-22 16:04:28 | 只看該作者
7#
發(fā)表于 2025-3-22 20:59:37 | 只看該作者
Metronomic Chemotherapy in Pediatric Malignanciesatriccancer. Maintenancelowdosechemotherapyhasproven itsbenefits in increasingoverallsurvival inseveral pediatric cancer. Thischapter isreviewingthecurrentknowledge ofpediatric metronomic chemotherapy and potential forfuture development ascytotoxic agents or in combinationwith targetedtherapy including its potentialapplicationinemergingcountries.
8#
發(fā)表于 2025-3-22 22:13:58 | 只看該作者
9#
發(fā)表于 2025-3-23 02:13:22 | 只看該作者
Preclinical Activity of Metronomic Regimens with Alkylating Agents and Antimetabolitesnomic chemotherapy approach. Much of this report concerns cyclophosphamide, since, in this context, it is the most widely explored drug so far. The report also draws attention to the numerous cancer cell lines and the main murine models used.
10#
發(fā)表于 2025-3-23 08:16:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 15:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
章丘市| 聊城市| 精河县| 白水县| 山东省| 开远市| 通化市| 九江市| 西城区| 华池县| 永丰县| 海兴县| 洪雅县| 潜山县| 瓮安县| 涡阳县| 凯里市| 江阴市| 昌都县| 本溪市| 汉源县| 井陉县| 都江堰市| 桂林市| 特克斯县| 谷城县| 白银市| 贡觉县| 阳山县| 丹棱县| 湘阴县| 澄城县| 遂平县| 牟定县| 静海县| 广水市| 呼玛县| 恩平市| 泾源县| 霍林郭勒市| 阜平县|